TreeWAS – Variant ID: rs11588387

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N72 Inflammatory disease of cervix uteri	0.000	0.969	0.031
N70-N77 Inflammatory diseases of female pelvic organs	0.000	0.980	0.020
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.000	0.982	0.018
N75 Diseases of Bartholin's gland	0.000	0.982	0.018
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.000	0.983	0.017
N70 Salpingitis and oophoritis	0.000	0.984	0.016
N75.0 Cyst of Bartholin's gland	0.000	0.984	0.016
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.000	0.985	0.014
N70.1 Chronic salpingitis and oophoritis	0.000	0.986	0.014
N71 Inflammatory disease of uterus, except cervix	0.000	0.986	0.014
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere	0.000	0.987	0.013
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere	0.000	0.987	0.013
N75.1 Abscess of Bartholin's gland	0.000	0.987	0.013
N75.9 Disease of Bartholin's gland, unspecified	0.000	0.987	0.013
N75.8 Other diseases of Bartholin's gland	0.000	0.987	0.013
T39.1 4-Aminophenol derivatives	0.000	0.988	0.012
N70.0 Acute salpingitis and oophoritis	0.000	0.988	0.012
N70.9 Salpingitis and oophoritis, unspecified	0.000	0.988	0.011
N76 Other inflammation of vagina and vulva	0.000	0.989	0.011
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere	0.000	0.989	0.010
N74.4 Female chlamydial pelvic inflammatory disease	0.000	0.989	0.010
N74.3 Female gonococcal pelvic inflammatory disease	0.000	0.989	0.010
N74.2 Female syphilitic pelvic inflammatory disease	0.000	0.989	0.010
N74.1 Female tuberculous pelvic inflammatory disease	0.000	0.989	0.010
N74.0 Tuberculous infection of cervix uteri	0.000	0.989	0.010
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.990	0.010
N71.0 Acute inflammatory disease of uterus	0.000	0.990	0.010
N71.1 Chronic inflammatory disease of uterus	0.000	0.990	0.010
N73 Other female pelvic inflammatory diseases	0.000	0.990	0.010
N71.9 Inflammatory disease of uterus, unspecified	0.000	0.990	0.010
T39.0 Salicylates	0.000	0.991	0.009
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.009	0.991	0.000
E22 Hyperfunction of pituitary gland	0.009	0.991	0.000
N76.8 Other specified inflammation of vagina and vulva	0.000	0.991	0.009
N76.6 Ulceration of vulva	0.000	0.991	0.008
E22.0 Acromegaly and pituitary gigantism	0.009	0.991	0.000
N76.0 Acute vaginitis	0.000	0.992	0.008
N76.5 Ulceration of vagina	0.000	0.992	0.008
N76.1 Subacute and chronic vaginitis	0.000	0.992	0.008
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.992	0.008
K56.5 Intestinal adhesions [bands] with obstruction	0.008	0.992	0.000
N76.3 Subacute and chronic vulvitis	0.000	0.992	0.008
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.992	0.008
T40.2 Other opioids	0.000	0.992	0.008
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.992	0.008
T39.4 Antirheumatics, not elsewhere classified	0.000	0.992	0.008
T39.2 Pyrazolone derivatives	0.000	0.992	0.008
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.992	0.008
E22.1 Hyperprolactinaemia	0.008	0.992	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.992	0.008
T40.4 Other synthetic narcotics	0.000	0.992	0.008
N73.8 Other specified female pelvic inflammatory diseases	0.000	0.993	0.007
N73.5 Female pelvic peritonitis, unspecified	0.000	0.993	0.007
N73.4 Female chronic pelvic peritonitis	0.000	0.993	0.007
N73.3 Female acute pelvic peritonitis	0.000	0.993	0.007
N73.2 Unspecified parametritis and pelvic cellulitis	0.000	0.993	0.007
N73.1 Chronic parametritis and pelvic cellulitis	0.000	0.993	0.007
N73.0 Acute parametritis and pelvic cellulitis	0.000	0.993	0.007
N76.4 Abscess of vulva	0.000	0.993	0.007
E20-E35 Disorders of other endocrine glands	0.007	0.993	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.007	0.993	0.000
E22.8 Other hyperfunction of pituitary gland	0.007	0.993	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.993	0.007
T40.6 Other and unspecified narcotics	0.000	0.993	0.006
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.993	0.006
E20 Hypoparathyroidism	0.006	0.994	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.006	0.994	0.000
E28 Ovarian dysfunction	0.006	0.994	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.994	0.006
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.994	0.006
T40.8 Lysergide [LSD]	0.000	0.994	0.006
T40.7 Cannabis (derivatives)	0.000	0.994	0.006
T40.5 Cocaine	0.000	0.994	0.006
T40.3 Methadone	0.000	0.994	0.006
T40.1 Heroin	0.000	0.994	0.006
T40.0 Opium	0.000	0.994	0.006
E21.0 Primary hyperparathyroidism	0.006	0.994	0.000
E20.9 Hypoparathyroidism, unspecified	0.006	0.994	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.994	0.006
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.994	0.006
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.994	0.006
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.994	0.006
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.994	0.006
T36 Poisoning by systemic antibiotics	0.000	0.994	0.006
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.994	0.006
E24 Cushing's syndrome	0.006	0.994	0.000
E28.2 Polycystic ovarian syndrome	0.006	0.994	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.994	0.006
N73.9 Female pelvic inflammatory disease, unspecified	0.000	0.994	0.005
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.994	0.006
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.995	0.005
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.005	0.995	0.000
N73.6 Female pelvic peritoneal adhesions	0.000	0.995	0.005
N76.2 Acute vulvitis	0.000	0.995	0.005
F10.0 Acute intoxication	0.005	0.995	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.005	0.995	0.000
E32 Diseases of thymus	0.005	0.995	0.000
E31 Polyglandular dysfunction	0.005	0.995	0.000
E30 Disorders of puberty, not elsewhere classified	0.005	0.995	0.000
E25 Adrenogenital disorders	0.005	0.995	0.000
E29 Testicular dysfunction	0.005	0.995	0.000
E27 Other disorders of adrenal gland	0.005	0.995	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.995	0.005
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.995	0.005
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.995	0.005
T46.7 Peripheral vasodilators	0.000	0.995	0.005
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.995	0.005
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.995	0.005
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.995	0.005
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.995	0.005
E24.2 Drug-induced Cushing's syndrome	0.005	0.995	0.000
E28.3 Primary ovarian failure	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.000	0.995	0.005
E34 Other endocrine disorders	0.005	0.995	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.995	0.005
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.995	0.005
T38.7 Androgens and anabolic congeners	0.000	0.995	0.005
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.995	0.005
T38.5 Other oestrogens and progestogens	0.000	0.995	0.005
T38.4 Oral contraceptives	0.000	0.995	0.005
T38.2 Antithyroid drugs	0.000	0.995	0.005
T38.1 Thyroid hormones and substitutes	0.000	0.995	0.005
T38.0 Glucocorticoids and synthetic analogues	0.000	0.995	0.005
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.995	0.005
E20.8 Other hypoparathyroidism	0.005	0.995	0.000
E20.1 Pseudohypoparathyroidism	0.005	0.995	0.000
E20.0 Idiopathic hypoparathyroidism	0.005	0.995	0.000
T42.1 Iminostilbenes	0.000	0.995	0.005
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.995	0.005
E21.5 Disorder of parathyroid gland, unspecified	0.005	0.995	0.000
E21.4 Other specified disorders of parathyroid gland	0.005	0.995	0.000
E21.2 Other hyperparathyroidism	0.005	0.995	0.000
E28.9 Ovarian dysfunction, unspecified	0.005	0.995	0.000
E28.8 Other ovarian dysfunction	0.005	0.995	0.000
E28.1 Androgen excess	0.005	0.995	0.000
E28.0 Oestrogen excess	0.005	0.995	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.995	0.005
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.995	0.005
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.995	0.005
T42.3 Barbiturates	0.000	0.995	0.005
T42.2 Succinimides and oxazolidinediones	0.000	0.995	0.005
T42.0 Hydantoin derivatives	0.000	0.995	0.005
T42.4 Benzodiazepines	0.000	0.995	0.005
E26 Hyperaldosteronism	0.005	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.995	0.004
E23 Hypofunction and other disorders of pituitary gland	0.004	0.995	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.996	0.004
T36.8 Other systemic antibiotics	0.000	0.996	0.004
T36.7 Antifungal antibiotics, systemically used	0.000	0.996	0.004
T36.6 Rifamycins	0.000	0.996	0.004
T36.5 Aminoglycosides	0.000	0.996	0.004
T36.4 Tetracyclines	0.000	0.996	0.004
T36.3 Macrolides	0.000	0.996	0.004
T36.2 Chloramphenicol group	0.000	0.996	0.004
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.996	0.004
T36.0 Penicillins	0.000	0.996	0.004
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.996	0.004
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.996	0.004
T37.5 Antiviral drugs	0.000	0.996	0.004
T37.4 Anthelminthics	0.000	0.996	0.004
T37.3 Other antiprotozoal drugs	0.000	0.996	0.004
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.996	0.004
T37.1 Antimycobacterial drugs	0.000	0.996	0.004
T37.0 Sulphonamides	0.000	0.996	0.004
T41.5 Therapeutic gases	0.000	0.996	0.004
T41.4 Anaesthetic, unspecified	0.000	0.996	0.004
T41.3 Local anaesthetics	0.000	0.996	0.004
T41.2 Other and unspecified general anaesthetics	0.000	0.996	0.004
T41.1 Intravenous anaesthetics	0.000	0.996	0.004
T41.0 Inhaled anaesthetics	0.000	0.996	0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.996	0.004
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.996	0.004
T47.7 Emetics	0.000	0.996	0.004
T47.6 Antidiarrhoeal drugs	0.000	0.996	0.004
T47.5 Digestants	0.000	0.996	0.004
T47.4 Other laxatives	0.000	0.996	0.004
T47.3 Saline and osmotic laxatives	0.000	0.996	0.004
T47.2 Stimulant laxatives	0.000	0.996	0.004
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.996	0.004
T47.0 Histamine H(2)-receptor antagonists	0.000	0.996	0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.996	0.004
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.004
T48.5 Anti-common-cold drugs	0.000	0.996	0.004
T48.4 Expectorants	0.000	0.996	0.004
T48.3 Antitussives	0.000	0.996	0.004
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.996	0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.996	0.004
T48.0 Oxytocic drugs	0.000	0.996	0.004
T49.9 Topical agent, unspecified	0.000	0.996	0.004
T49.8 Other topical agents	0.000	0.996	0.004
T49.7 Dental drugs, topically applied	0.000	0.996	0.004
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.996	0.004
T49.5 Ophthalmological drugs and preparations	0.000	0.996	0.004
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.996	0.004
T49.3 Emollients, demulcents and protectants	0.000	0.996	0.004
T49.2 Local astringents and local detergents	0.000	0.996	0.004
T49.1 Antipruritics	0.000	0.996	0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.996	0.004
E27.9 Disorder of adrenal gland, unspecified	0.004	0.996	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.004	0.996	0.000
E24.8 Other Cushing's syndrome	0.004	0.996	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.004	0.996	0.000
E24.3 Ectopic ACTH syndrome	0.004	0.996	0.000
E24.1 Nelson's syndrome	0.004	0.996	0.000
E24.0 Pituitary-dependent Cushing's disease	0.004	0.996	0.000
N85.0 Endometrial glandular hyperplasia	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.996	0.004
E27.2 Addisonian crisis	0.004	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.996	0.004
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.004
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.996	0.004
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.004
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.004
T44.0 Anticholinesterase agents	0.000	0.996	0.004
E24.9 Cushing's syndrome, unspecified	0.004	0.996	0.000
E27.8 Other specified disorders of adrenal gland	0.004	0.996	0.000
E25.9 Adrenogenital disorder, unspecified	0.004	0.996	0.000
E25.8 Other adrenogenital disorders	0.004	0.996	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.004	0.996	0.000
E30.9 Disorder of puberty, unspecified	0.004	0.996	0.000
E30.8 Other disorders of puberty	0.004	0.996	0.000
E30.1 Precocious puberty	0.004	0.996	0.000
E30.0 Delayed puberty	0.004	0.996	0.000
E31.9 Polyglandular dysfunction, unspecified	0.004	0.996	0.000
E31.8 Other polyglandular dysfunction	0.004	0.996	0.000
E31.1 Polyglandular hyperfunction	0.004	0.996	0.000
E31.0 Autoimmune polyglandular failure	0.004	0.996	0.000
E32.9 Disease of thymus, unspecified	0.004	0.996	0.000
E32.8 Other diseases of thymus	0.004	0.996	0.000
E32.1 Abscess of thymus	0.004	0.996	0.000
E32.0 Persistent hyperplasia of thymus	0.004	0.996	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.004	0.996	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.004	0.996	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.004	0.996	0.000
N95.8 Other specified menopausal and perimenopausal disorders	0.004	0.996	0.000
E29.9 Testicular dysfunction, unspecified	0.004	0.996	0.000
E29.8 Other testicular dysfunction	0.004	0.996	0.000
E29.0 Testicular hyperfunction	0.004	0.996	0.000
E27.5 Adrenomedullary hyperfunction	0.004	0.996	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.004	0.996	0.000
E27.0 Other adrenocortical overactivity	0.004	0.996	0.000
K70.9 Alcoholic liver disease, unspecified	0.000	0.996	0.004
E27.4 Other and unspecified adrenocortical insufficiency	0.004	0.996	0.000
Z48.0 Attention to surgical dressings and sutures	0.000	0.996	0.004
E29.1 Testicular hypofunction	0.004	0.996	0.000
E34.8 Other specified endocrine disorders	0.004	0.996	0.000
E34.5 Androgen resistance syndrome	0.004	0.996	0.000
E34.4 Constitutional tall stature	0.004	0.996	0.000
E34.3 Short stature, not elsewhere classified	0.004	0.996	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.004	0.996	0.000
E34.1 Other hypersecretion of intestinal hormones	0.004	0.996	0.000
E34.0 Carcinoid syndrome	0.004	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.996	0.004
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.996	0.004
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.996	0.004
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene	0.004	0.996	0.000
S22.30 Fracture of rib (closed)	0.004	0.996	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
K70.3 Alcoholic cirrhosis of liver	0.000	0.996	0.004
E26.9 Hyperaldosteronism, unspecified	0.003	0.996	0.000
E26.8 Other hyperaldosteronism	0.003	0.996	0.000
E26.1 Secondary hyperaldosteronism	0.003	0.996	0.000
E21.3 Hyperparathyroidism, unspecified	0.004	0.996	0.000
K70 Alcoholic liver disease	0.000	0.996	0.004
E23.2 Diabetes insipidus	0.003	0.996	0.000
T50.8 Diagnostic agents	0.000	0.996	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.996	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.996	0.003
T50.5 Appetite depressants	0.000	0.996	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.996	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.996	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.996	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.996	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.996	0.003
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.996	0.004
E23.7 Disorder of pituitary gland, unspecified	0.003	0.996	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.003	0.996	0.000
E23.1 Drug-induced hypopituitarism	0.003	0.996	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
E34.9 Endocrine disorder, unspecified	0.003	0.997	0.000
K41 Femoral hernia	0.003	0.997	0.000
E23.6 Other disorders of pituitary gland	0.003	0.997	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.003
T45.4 Iron and its compounds	0.000	0.997	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
S22.10 Multiple fractures of thoracic spine (closed)	0.003	0.997	0.000
T45.5 Anticoagulants	0.000	0.997	0.003
M79.66 Pain in limb (Lower leg)	0.000	0.997	0.003
E26.0 Primary hyperaldosteronism	0.003	0.997	0.000
K70.4 Alcoholic hepatic failure	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
K70.0 Alcoholic fatty liver	0.000	0.997	0.003
S22.3 Fracture of rib	0.003	0.997	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.997	0.003
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.002
S22.1 Multiple fractures of thoracic spine	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.001	0.997	0.002
K41.4 Unilateral or unspecified femoral hernia, with gangrene	0.003	0.997	0.000
K41.2 Bilateral femoral hernia, without obstruction or gangrene	0.003	0.997	0.000
K41.1 Bilateral femoral hernia, with gangrene	0.003	0.997	0.000
K41.0 Bilateral femoral hernia, with obstruction, without gangrene	0.003	0.997	0.000
E27.1 Primary adrenocortical insufficiency	0.002	0.997	0.000
K70.1 Alcoholic hepatitis	0.000	0.997	0.003
N81.6 Rectocele	0.000	0.997	0.003
Z85.6 Personal history of leukaemia	0.000	0.997	0.003
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.997	0.003
R73.0 Abnormal glucose tolerance test	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.000	0.997	0.003
E23.0 Hypopituitarism	0.002	0.997	0.000
K75.8 Other specified inflammatory liver diseases	0.000	0.997	0.002
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.003	0.997	0.000
S22 Fracture of rib(s), sternum and thoracic spine	0.002	0.997	0.000
S22.31 Fracture of rib (open)	0.002	0.998	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
K75 Other inflammatory liver diseases	0.000	0.998	0.002
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.002	0.998	0.000
M25.46 Effusion of joint (Lower leg)	0.000	0.998	0.002
F20.0 Paranoid schizophrenia	0.002	0.998	0.000
S22.11 Multiple fractures of thoracic spine (open)	0.002	0.998	0.000
M13.00 Polyarthritis, unspecified (Multiple sites)	0.002	0.998	0.000
K04.7 Periapical abscess without sinus	0.000	0.998	0.002
S22.4 Multiple fractures of ribs	0.002	0.998	0.000
K70-K77 Diseases of liver	0.000	0.998	0.002
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.002	0.998	0.000
F17.2 Dependence syndrome	0.002	0.998	0.000
K75.9 Inflammatory liver disease, unspecified	0.000	0.998	0.002
K76.8 Other specified diseases of liver	0.000	0.998	0.002
F10.4 Withdrawal state with delirium	0.002	0.998	0.000
K72.9 Hepatic failure, unspecified	0.000	0.998	0.002
S22.40 Multiple fractures of ribs (closed)	0.002	0.998	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.002	0.998	0.000
Z53.9 Procedure not carried out, unspecified reason	0.002	0.998	0.000
F10.6 Amnesic syndrome	0.002	0.998	0.000
K72 Hepatic failure, not elsewhere classified	0.000	0.998	0.002
S22.5 Flail chest	0.002	0.998	0.000
F10.5 Psychotic disorder	0.002	0.998	0.000
L60.0 Ingrowing nail	0.000	0.998	0.002
S22.9 Fracture of bony thorax, part unspecified	0.002	0.998	0.000
S22.8 Fracture of other parts of bony thorax	0.002	0.998	0.000
K76 Other diseases of liver	0.000	0.998	0.002
S52.50 Fracture of lower end of radius (closed)	0.000	0.998	0.002
F10.8 Other mental and behavioural disorders	0.002	0.998	0.000
F10.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
Q54.0 Hypospadias, balanic	0.002	0.998	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.998	0.002
K75.2 Nonspecific reactive hepatitis	0.000	0.998	0.002
K75.1 Phlebitis of portal vein	0.000	0.998	0.002
F10.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
Z43.2 Attention to ileostomy	0.002	0.998	0.000
S22.41 Multiple fractures of ribs (open)	0.002	0.998	0.000
J47 Bronchiectasis	0.002	0.998	0.000
K77 Liver disorders in diseases classified elsewhere	0.000	0.998	0.002
K71 Toxic liver disease	0.000	0.998	0.002
S52.00 Fracture of upper end of ulna (closed)	0.000	0.998	0.002
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.002	0.998	0.000
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.000	0.998	0.002
F10.1 Harmful use	0.002	0.998	0.000
F17 Mental and behavioural disorders due to use of tobacco	0.002	0.998	0.000
K73 Chronic hepatitis, not elsewhere classified	0.000	0.998	0.002
S22.2 Fracture of sternum	0.002	0.998	0.000
S22.50 Flail chest (closed)	0.002	0.998	0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
C50.4 Upper-outer quadrant of breast	0.002	0.998	0.000
K72.1 Chronic hepatic failure	0.000	0.998	0.002
K76.9 Liver disease, unspecified	0.000	0.998	0.002
S22.51 Flail chest (open)	0.002	0.998	0.000
K75.4 Autoimmune hepatitis	0.000	0.998	0.002
F20 Schizophrenia	0.002	0.998	0.000
K75.0 Abscess of liver	0.000	0.998	0.002
S22.81 Fracture of other parts of bony thorax (open)	0.001	0.998	0.000
S22.80 Fracture of other parts of bony thorax (closed)	0.001	0.998	0.000
S22.91 Fracture of bony thorax, part unspecified (open)	0.001	0.998	0.000
S22.90 Fracture of bony thorax, part unspecified (closed)	0.001	0.998	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.002	0.998	0.000
K76.7 Hepatorenal syndrome	0.000	0.998	0.002
K76.5 Hepatic veno-occlusive disease	0.000	0.998	0.002
K76.4 Peliosis hepatis	0.000	0.998	0.002
K76.3 Infarction of liver	0.000	0.998	0.002
K76.2 Central haemorrhagic necrosis of liver	0.000	0.998	0.002
K76.1 Chronic passive congestion of liver	0.000	0.998	0.002
D69 Purpura and other haemorrhagic conditions	0.000	0.998	0.002
I71.0 Dissection of aorta [any part]	0.002	0.998	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.002	0.998	0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.002	0.998	0.000
H90.3 Sensorineural hearing loss, bilateral	0.000	0.998	0.002
N08.3 Glomerular disorders in diabetes mellitus	0.000	0.998	0.002
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.002	0.998	0.000
K14.8 Other diseases of tongue	0.000	0.998	0.002
K76.6 Portal hypertension	0.000	0.998	0.002
T82.5 Mechanical complication of other cardiac and vascular devices and implants	0.002	0.998	0.000
K71.9 Toxic liver disease, unspecified	0.000	0.998	0.001
K71.8 Toxic liver disease with other disorders of liver	0.000	0.998	0.001
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.998	0.001
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.998	0.001
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.998	0.001
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.998	0.001
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.998	0.001
K71.2 Toxic liver disease with acute hepatitis	0.000	0.998	0.001
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.998	0.001
K71.0 Toxic liver disease with cholestasis	0.000	0.998	0.001
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.998	0.001
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.002	0.998	0.000
S92.30 Fracture of metatarsal bone (closed)	0.002	0.998	0.000
S22.0 Fracture of thoracic vertebra	0.001	0.998	0.000
F23 Acute and transient psychotic disorders	0.002	0.998	0.000
D69.6 Thrombocytopenia, unspecified	0.000	0.998	0.002
F17.9 Unspecified mental and behavioural disorder	0.001	0.998	0.000
F17.8 Other mental and behavioural disorders	0.001	0.998	0.000
F17.7 Residual and late-onset psychotic disorder	0.001	0.998	0.000
F17.6 Amnesic syndrome	0.001	0.998	0.000
F17.5 Psychotic disorder	0.001	0.998	0.000
F17.4 Withdrawal state with delirium	0.001	0.998	0.000
F17.3 Withdrawal state	0.001	0.998	0.000
F17.0 Acute intoxication	0.001	0.998	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.998	0.001
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.998	0.001
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.998	0.001
Q54 Hypospadias	0.002	0.998	0.000
S22.21 Fracture of sternum (open)	0.001	0.998	0.000
J95.8 Other postprocedural respiratory disorders	0.002	0.998	0.000
K73.9 Chronic hepatitis, unspecified	0.000	0.998	0.001
S92.00 Fracture of calcaneus (closed)	0.002	0.998	0.000
F20.9 Schizophrenia, unspecified	0.002	0.998	0.000
K72.0 Acute and subacute hepatic failure	0.000	0.998	0.001
K11.5 Sialolithiasis	0.000	0.998	0.002
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.998	0.001
F20.8 Other schizophrenia	0.001	0.998	0.000
F20.6 Simple schizophrenia	0.001	0.998	0.000
F20.5 Residual schizophrenia	0.001	0.998	0.000
F20.4 Postschizophrenic depression	0.001	0.998	0.000
F20.3 Undifferentiated schizophrenia	0.001	0.998	0.000
F20.2 Catatonic schizophrenia	0.001	0.998	0.000
F20.1 Hebephrenic schizophrenia	0.001	0.998	0.000
D69.8 Other specified haemorrhagic conditions	0.000	0.998	0.001
D69.2 Other nonthrombocytopenic purpura	0.000	0.998	0.001
D69.1 Qualitative platelet defects	0.000	0.998	0.001
J98.1 Pulmonary collapse	0.002	0.998	0.000
I71 Aortic aneurysm and dissection	0.002	0.998	0.000
D69.5 Secondary thrombocytopenia	0.000	0.998	0.001
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.001	0.998	0.000
R47.8 Other and unspecified speech disturbances	0.000	0.998	0.002
Z11.2 Special screening examination for other bacterial diseases	0.001	0.998	0.000
C43.5 Malignant melanoma of trunk	0.001	0.999	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.001	0.999	0.000
Q54.9 Hypospadias, unspecified	0.001	0.999	0.000
S92.3 Fracture of metatarsal bone	0.001	0.999	0.000
T79.7 Traumatic subcutaneous emphysema	0.001	0.999	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.001	0.999	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.001	0.999	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.001	0.999	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.001	0.999	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.001	0.999	0.000
D69.0 Allergic purpura	0.000	0.999	0.001
F23.8 Other acute and transient psychotic disorders	0.001	0.999	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.001	0.999	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.001	0.999	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.001	0.999	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.001	0.999	0.000
N80.1 Endometriosis of ovary	0.000	0.999	0.001
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.001	0.999	0.000
S22.01 Fracture of thoracic vertebra (open)	0.001	0.999	0.000
D69.4 Other primary thrombocytopenia	0.000	0.999	0.001
S92.0 Fracture of calcaneus	0.001	0.999	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.001	0.999	0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.999	0.001
Q54.8 Other hypospadias	0.001	0.999	0.000
Q54.4 Congenital chordee	0.001	0.999	0.000
Q54.3 Hypospadias, perineal	0.001	0.999	0.000
Q54.2 Hypospadias, penoscrotal	0.001	0.999	0.000
Q54.1 Hypospadias, penile	0.001	0.999	0.000
Z98.8 Other specified postsurgical states	0.001	0.999	0.000
H90 Conductive and sensorineural hearing loss	0.000	0.999	0.001
F19.1 Harmful use	0.001	0.999	0.000
J95.9 Postprocedural respiratory disorder, unspecified	0.001	0.999	0.000
Q05.9 Spina bifida, unspecified	0.001	0.999	0.000
T79.8 Other early complications of trauma	0.001	0.999	0.000
F17.1 Harmful use	0.001	0.999	0.000
Z11.0 Special screening examination for intestinal infectious diseases	0.001	0.999	0.000
M06.9 Rheumatoid arthritis, unspecified	0.001	0.999	0.000
T23.3 Burn of third degree of wrist and hand	0.001	0.999	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.001	0.999	0.000
F11 Mental and behavioural disorders due to use of opioids	0.001	0.999	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.001	0.999	0.000
S37.00 Injury of kidney (without open wound into cavity)	0.001	0.999	0.000
F19.9 Unspecified mental and behavioural disorder	0.001	0.999	0.000
F19.8 Other mental and behavioural disorders	0.001	0.999	0.000
F19.7 Residual and late-onset psychotic disorder	0.001	0.999	0.000
F19.6 Amnesic syndrome	0.001	0.999	0.000
F19.5 Psychotic disorder	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations